Drugstore industry
Article Abstract:
Pressure from the Federal Trade Commission and a number of states caused Rite Aid Corp to call off its proposed acquisition of Revco DS Inc, and future drug chain mergers will probably be frowned on by regulators. A price discrimination suit among independent drugstores, drug chains, and 11 drug manufacturers has also been settled. Most drug chain stocks will likely underperform the market in 1996 and 1997, but several are timely selections.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Drugstore industry
Article Abstract:
Merger activity in the drug store industry has increased in the last months of 1996, and stocks in this industry have risen in timeliness as a result. Demands by third-party plan providers have forced the gross domestic profit margins of the industry decrease in 1996, although margins are expected to stabilize. Several drugstore chains are expected to generate good earnings through the end of the 1990s and the industry will remain timely.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Drugstore industry
Article Abstract:
Drugstore chains have increased the pace of friendly mergers and hostile takeovers and investors may expect to see the industry dominated by a small number of companies. Companies that have a history of long term profitability, the ability to meet competition, build growth and market share offer the best future prospects.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 1996
User Contributions:
Comment about this article or add new information about this topic: